RECRUITINGOBSERVATIONAL
Role of the Immune Environment in Response to Therapy in Breast Cancer
About This Trial
This is an observational case-control study of tissues collected from women with ER+HER2- breast cancers. The immune environments of these cancers will be compared to triple negative and HER2+ breast cancers. No randomization or changes to standard of care treatment will occur as part of the study.
Who May Be Eligible (Plain English)
Who May Qualify:
Women 18 years of age or older with non-metastatic breast cancer undergoing surgical resection in the University of Pennsylvania Health System.
Who Should NOT Join This Trial:
Males Children Pregnant individuals
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion criteria:
Women 18 years of age or older with non-metastatic breast cancer undergoing surgical resection in the University of Pennsylvania Health System.
Exclusion criteria:
Males Children Pregnant individuals
Treatments Being Tested
OTHER
Collection of personal health information from women treated at the University of Pennsylvania under an approved HIPAA waiver.
Collection of personal health information from women treated at the University of Pennsylvania under an approved HIPAA waiver.
Locations (1)
Abramson Cancer Center
Philadelphia, Pennsylvania, United States